Dr Faisal Sultan, Special Assistant to the Prime Minister for Health, said on Wednesday that Pakistan was in high-level talks with two manufacturers to procure the CoV-19 vaccine.
Addressing a press conference in Islamabad, he said that these two companies were Sinofram and Kensno.
Dr. Faisal said that synoform is being used in many countries, and its effectiveness is about 80-85%. Meanwhile, Kensano’s Phase III is being rolled out in Pakistan, and is expected to be completed soon, the Special Assistant said, adding that the results of the vaccine will be available soon.
About 17,500 people participated in the vaccine trials. Dr. Sultan said that the trials in three of the five centers have been completed, while they are nearing completion in two centers.
“Statistical analysis of the vaccine has begun and we expect results in early February,” he said. He added that Pakistan is entitled to 20 million doses on the condition that the vaccine is effective.
In addition, through the WHO facility of the World Health Organization, Pakistan is expected to receive free vaccines for 20% of the country’s population.
More than four high-income economies have joined the CoVID fidelity, a global initiative that brings governments and manufacturers together to ensure that the COVID-19 vaccine finally reaches the most needy. Can
Negotiations are needed at the government level to ensure that Pakistan can benefit from food through Caucasus. “And our officials are in touch with Chinese officials,” Dr. Sultan said.
“Today, we also met with the British ambassador and I assure you that we will announce some positive results soon,” he said.
Talking about the current procurement situation, the Special Assistant said that the government would be able to procure 1 million doses of vaccine in the first quarter (January-March). “We are confident that we will be able to get more food in the future,” he said.
Talking about statistics, he said that the population of the country is 220 million, while the number of people under the age of 18 is about 120 million. “This vaccine has been approved for the adult population and if we can vaccinate 70 per cent of our population, I expect the country to get immunity.”
Standards for vaccines
Dr Sultan said the technical committee tasked with reviewing candidates for the corona virus vaccine would have to consider several aspects before choosing one of them.
The aspects that were analyzed were:
What technology was used?
Is the vaccine safe? What are the side effects?
The vaccine needs a cold chain
How much can a company produce?
How can it be provided in Pakistan?
The committee initiated talks with eight shortlisted companies and took the talks further. On the other hand, it is also registering companies whose results are available.
He said that Drug Regulatory Authority of Pakistan (DRP) had in the last few days approved vaccines against Austenesic and Synoform.
How will Pakistan distribute vaccines?
He said Pakistan would distribute the vaccine through the Expanded Program on Immunization (EPI), and the country was able to vaccinate its entire population.
To facilitate this process, the government has developed software to track it. “About 400,000 health workers are enrolled in the resource management system.”
“The training involves thousands of people – frontline health workers, technical staff, logistics, and waste management.”
Elaborating on the immunization stages, he said frontline healthcare workers would be the first to receive the vaccine.
In the next phase, the rest of the healthcare workers and people over the age of 65 will receive the pills.
Then, the population over 60 and over 18 will be vaccinated.
“I reiterate that this vaccine will be free,” said the aide to the prime minister.
Dr Sultan clarified that the private sector and provincial governments are free to take their own vaccines if needed.